Decreased Expression of the FOXO3a Gene Is Associated with Poor Prognosis in Primary Gastric Adenocarcinoma Patients
Figure 1
Real-time quantitative RT-PCR analysis of FOXO3a expression in gastric cancer surgical specimens.
The relative mRNA expression of FOXO3a was significantly lower in 24 of 35 (68.6%) gastric cancer tissues compared with the corresponding non-tumorous tissues. (FOXO3a/GAPDH, n = 35, p = 0.03).